Organization Overview
Historical Acquisition Tree
Alternative names
bexagliflozin (Brenzavvy) (2023 NDA)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Essential Hypertension (Phase 3)
Hypertension (Phase 3)
Obesity (Phase 2)
Overweight (Phase 1)